Philippines Radiotherapy Market Detailed In New Research Report 2021 | Elekta AB, Accuray Incorporated, Varian Medical Systems, Inc.

Philippines Radiotherapy Market to Surpass US$ 27.7 Mn Threshold by 2026 - Coherent Market Insights

Major market players are focusing on installing and increasing access of their technologically advanced radiotherapy products in the Philippines market. For instance, in 2015, Elekta installed new version Gamma Knife Perfexion stereotactic radiosurgery system at the Philippines Gamma Knife Center. Thus, installment of such novel devices in Philippines is expected to drive growth of the Philippines radiotherapy market growth over the forecast period.

Similarly, in 2012, TomoTherapy, system a fully-integrated, 3D image-guided intensity modulated radiation therapy (IG-IMRT) manufactured by Accuray Incorporated, was made available in Makati Medical Center in Manila, Philippines.

To Get more Business Statergies Request for Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/2601

The increasing prevalence of cancer in Philippines is one of the major factors that is expected to drive demand for radiotherapy treatment and further expected to augment growth of the Philippines radiotherapy market growth over the forecast period. For instance, according to the data published by the World Health Organization (WHO), around 28,700 males and 27,900 females in the Philippines died from cancer, in 2014.

Browse 30 Market Data Tables and 31 Figures spread through 160 Pages and in-depth TOC on Philippines Radiotherapy Market, by Product Type (External Beam Radiotherapy Device, Linear Accelerators (LINAC), Advanced Radiotherapy Device, Cobalt-60 Teletherapy System, Internal Radiotherapy (Brachytherapy) Device, and Systemic Radiotherapy), by Procedure Type (External Beam Radiotherapy, 3-D Conformal Radiation Therapy, Intensity-modulated Radiation Therapy (IMRT), Image-guided Radiation Therapy (IGRT) & Tomotherapy, Stereotactic Radiosurgery & Stereotactic Body Radiation Therapy, and Others), by Application (Breast Cancer, Lung Cancer, Cervical Cancer, Prostate Cancer, Head & Neck Cancer, Hematologic Cancer, and Others), and by End User (Hospitals and Cancer Research Institutes) – Philippines Forecast to 2026

Several organizations are focusing on different initiatives to raise awareness about different types of cancers and its treatment, among populace and such initiatives are expected to support and increase adoption of novel cancer treatment methods including radiotherapy. For instance, in February 2018, MSD Philippines entered into a partnership with Philippines Society of Oncologists (PSO) and Philippines Society of Medical Oncology (PSMO) to launch World Cancer Day forum to spread awareness regarding cancer and its treatment.

To Get Research PDF Brochure Here @ https://www.coherentmarketinsights.com/insight/request-pdf/2601

Key Takeaways of the Philippines Radiotherapy Market:

• The Philippines radiotherapy market is expected to exhibit a CAGR of 5.8% over the forecast period (2018-2026), which is attributed to increasing prevalence of cancer, frequent initiatives by various organizations for cancer treatment, and increasing focus of key players to install novel radiotherapy devices in region

• Among application, breast cancer segment is expected to hold a dominant position over the forecast period. The segment growth is attributed to high prevalence of breast cancer in the Philippines. For instance, according to the data published by Philippine Cancer Society in 2015, prevalence of breast cancer is the highest as compared to other cancers and it accounts for 19% of all cancer cases in the Philippines.

• The cost of radiotherapy is high and is not easily affordable to low and middle income population. However, benefits and reimbursements provided by PhilHealth may support adoption of radiotherapy in the Philippines and drive the market growth over the forecast period.

• Key players operating in the Philippines Radiotherapy market include Elekta AB, Accuray Incorporated, Varian Medical Systems, Inc., RaySearch Laboratories AB, Mevion Medical Systems, Inc., Isoray, Inc., Nordion, Inc., Becton, Dickinson and Company, Ion Beam Applications SA, and Hitachi, Ltd.

To Direct Purchase this Research Report – https://www.coherentmarketinsights.com/insight/buy-now/2601

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.